Clinical and Experimental Evidence of Hypoglycemic Neuropathy
DOI:
https://doi.org/10.17140/DROJ-1-121Keywords:
Hypoglycemic neuropathy, Hypoglycemia, Peripheral nervous systemAbstract
When compared with the extensive research on hypoglycemic impacts on Central Nervous System (CNS) and cardiovascular system, the effects of hypoglycemia on the Peripheral Nervous System (PNS) have not been investigated as thoroughly. Epidemiologic data and risk factors for hypoglycemic neuropathy are still lacking. Interestingly, hyperglycemia mainly results in the damage of sensory and autonomic nerve fibers, whereas hypoglycemia predominantly leads to the development of motor neuropathy. Most clinical features are concluded from patients with insulinoma, and neuropathology has shown axonal degeneration in large myelinated
fibers. Experimental animal models support the clinical and histopathological findings. The exact pathophysiological mechanisms of hypoglycemic neuropathy remain elusive. The influence of hypoglycemia on peripheral nervous system warrants further investigations.
References
Cryer PE, Davis SN, Shamoon H. Hypoglycemia in dia-betes diabetes care. 2003; 26: 1902-1912. doi: 10.2337/dia-care.26.6.1902
Shafiee G1, Mohajeri-Tehrani M, Pajouhi M, et al. The im-portance of hypoglycemia in diabetic patients. J Diabetes Metab Disord. 2012; 11(1): 17-24. doi: 10.1186/2251-6581-11-17
Workgroup on Hypoglycemia, American Diabetes Associa-tion. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association workgroup on hypo-glycemia. Diabetes Care. 2005; 28: 1245-1249. doi: 10.2337/ diacare.28.5.1245
American Diabetes Association. Standard of medical care in diabetes-2015. Diabetes Care. 2015; 38(1): S1-S2. doi: 10.2337/ dc15-S001
Gabriely I, Shamoon H. Hypoglycemia in diabetes: common, often unrecognized. Cleve Clin J Med. 2004; 71: 335-342.
Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010; 363: 1410-1418. doi: 10.1056/NEJMoa1003795
Hanefeld M, Duetting E, Bramlage P. Cardiac implications of hypoglycaemia in patients with diabetes: a systematic re-view. Cardiovascular Diabetology. 2013; 12: 135-146. doi: 10.1186/1475-2840-12-135
Lin KYH, Huang KJ, Yang CP. Glycemic variability: clinical and prognostic significance. Diabetes Res Open J. 2015; 1: 48- 53. doi: 10.17140/DROJ-1-108
Yang CP, Lin CC, Li CI, et al. Cardiovascular risk factors increase the risks of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. Medicine (Baltimore). 2015; 94: e1783. doi: 10.1097/MD.0000000000001783
Mohseni S. Hypoglycemic neuropathy. Acta Neuropathol. 2001; 102: 413-421.
Mohseni S. Neurologic damage in hypoglycemia. Handb Clin Neurol. 2014; 126: 513-532.
Jensen VF, Mølck AM, Bøgh IB, et al. Effect of insulin-in-duced hypoglycaemia on the peripheral nervous system: focus on adaptive mechanisms, pathogenesis and histopathological changes. J Neuroendocrinol. 2014; 26: 482-496. doi: 10.1111/ jne.12170
Silfverskiöld BP. Polyneuritis hypoglycemica. Late periph-eral paresis after hypoglycemic attacks in two insulinoma pa-tients. Acta Med Scand. 1946; 125: 502-504.
Mulder DW, Bastron JA, Lambert EH. Hyperinsulin neu-ronopathy. Neurology. 1956; 6: 627-635. doi: 10. 1212/WNL.6. 9. 627
Harrison MJG Muscle wasting after prolonged hypoglyce-mic coma: case report with electrophysiological data. J Neurol Neurosurg Psychiatry. 1976; 39: 465-470.
Williams CJ. Amyotrophy due to hypoglycemia. Br Med J. 1955; 1: 707-708.
Tom MI, Richardson JC. Hypoglycemia from islet celltu-mor of pancreas with amyotrophy and cerebrospinal nervecell changes. J Neuropathol Exp Neurol. 1951; 10: 57-66.
Jayasinghe KS, Nimalasuriya A, Dharmadasa K. A case of insulinoma with peripheral neuropathy. Postgrad Med J. 1983; 59: 189-190.
Tintore M, Montalban J, Cervera C, et al. Peripheral neu-ropathy in association with insulinoma: clinical features and neuropathology of a new case. J Neurol Neurosurg Psychiatry. 1994; 57: 1009-1010.
Jaspan JB, Wollman RL, Bernstein L, et al. Hypoglycemic peripheral neuropathy in association with insulinoma: implica-tion of glucopenia rather than hyperinsulinism. Medicine (Balti-more). 1982; 61: 33–44.
Tamburrano G, Locuratolo N, Pozzessere G, et al. Changes in central and peripheral nervous system function during hypo-glycemia in man: an electro-physiological quantification. J En-docrinol Invest. 1992; 15: 279-282. doi: 10.1007/BF03348728
Heckmann JG, Dietrich W, Hohenberger W, et al. Hy-poglycemic sensorimotor polyneuropathy associated with insulinoma. Muscle Nerve. 2000; 23: 1891-1894. doi: 10.1002/1097-4598(200012)23:12<1891::AID-MUS17>3.0. CO;2-Y
Striano S, Striano P, Manganelli F, et al. Distal hypoglycemic neuropathy. An insulinoma-associated case, misdiagnosed as temporal lobe epilepsy. Neurophysiol Clin. 2003; 33: 223-227. doi: 10.1016/j.neucli.2003.08.001
Brown AM, Evans RD, Black J, et al. Schwann cell glyco-gen selectively supports myelinated axon function. Ann Neurol. 2012; 3: 406-418.
Mohseni S, Hildebrand C. Neuropathy in diabetic BB/W or rats treated with insulin implants. Acta Neuropathol. 1998; 96: 144-150.
Potter CG, Sharma AK, Farber MO, et al. Hypoglycemic neuropathy in experimental diabetes. J Neurol Sci. 1988; 88: 293-301. doi: 10.1016/0022-510X(88)90226-2
Sidenius P, Jakobsen J. Peripheral neuropathy in rats induced by insulin treatment. Diabetes. 1983; 32: 383-386. doi: 10.2337/ diab.32.4.383
Sima AAF, Zhang WX, Greene DA. Diabetic and hypogly-cemic neuropathy-a comparison in the BB rat. Diabetes Res Clin Pract. 1989; 6: 279-296.
Yasaki S, Dyck PJ. Duration and severity of hypoglycemia needed to induce neuropathy. Brain Res. 1990; 531: 8-15. doi: 10.1016/0006-8993(90)90752-W
Yasaki S, Dyck PJ. Spatial distribution of fiber degeneration in acute hypoglycemic neuropathy in rat. J Neuropath Exp Neu-rol. 1991; 50: 681-692.
Mohseni S. Hypoglycemic neuropathy in diabetic BB/W or rats treated with insulin implants affects ventral root axons but not dorsal root axons. Acta Neuropathol. 2000; 100: 415-420. doi: 10.1007/s004010000204
Sima AA, Zhang WX, Greene DA. Diabetic and hypoglyce-mic neuropathy-a comparison in the BB rat. Diabetes Res Clin Pract. 1989; 6: 279-296. doi: 10.1016/0168-8227(89)90068-5
Westfall SG, Felten DL, Mandelbaum JA, et al. Degenera-tive neuropathy in insulin-treated diabeticrats. J Neurol Sci. 1983; 61: 93-107. doi: 10.1016/0022-510X(83)90057-6
Ohshima J, Nukada H. Hypoglycaemic neuropathy: micro-vascular changes due to recurrent hypoglycaemic episodes in rat sciatic nerve. Brain Res. 2002; 1: 84-89. doi: 10.1016/S0006- 8993(02)02910-4
Corfas G, Velardez M, Ko C, et al. Mechanisms and roles of axon-Schwann cell interactions. J Neurosci. 2004; 42: 9250- 9260. doi: 10. 1523/ JNEUROSCI.3649-04.2004
Low P, Yao J, Kishi Y, et al. Peripheral nerve energy metabolism in experimental diabetic neuropathy. Neuro-sci Res Commun. 1997; 1: 49-56. doi: 10.1002/(SICI)1520- 6769(199707)21:1<49::AID-NRC207>3.0.CO;2-T
Low P, Lagerlund T, McManis P. Nerve blood-flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol. 1989; 31: 355-438. doi: 10.1016/S0074- 7742(08)60283-4
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
